Goldan Keith A. Insider Trades

Insider Trading History

Track insider trading activity for Goldan Keith A.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $2.51M 139,252 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$22.4k 1,177 shares
$18.99
$18.02
Abeona Therapeutics
Abeona Therapeutics ABEO
Director
Holding Value $191k 32,751 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 32,751 shares
$4.58
$5.82
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $2.53M 140,429 shares
Last Trade
Feb 09, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$71.7k 3,410 shares
$21.03
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $2.59M 143,839 shares
Last Trade
Feb 06, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.9k 2,082 shares
$20.62
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $2.63M 145,921 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.49M 170,250 shares
$20.48
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $1.69M 93,671 shares
Last Trade
Jan 30, 2026 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$24.8k 1,219 shares
$20.31
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $1.67M 92,452 shares
Last Trade
Dec 01, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$23.4k 1,224 shares
$19.12
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $1.69M 93,676 shares
Last Trade
Jul 31, 2025 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$12.2k 1,226 shares
$9.92
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $1.67M 92,450 shares
Last Trade
Jul 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$12k 1,296 shares
$9.29
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $1.69M 93,746 shares
Last Trade
May 19, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$27.9k 3,000 shares
$9.30
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $1.64M 90,746 shares
Last Trade
Feb 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$58.5k 3,777 shares
$15.50
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $1.99M 110,500 shares
Last Trade
Feb 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.62M 110,500 shares
$14.65
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $948k 52,623 shares
Last Trade
Jun 14, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25k 1,250 shares
$20.03
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $1.26M 70,000 shares
Last Trade
Feb 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.56M 70,000 shares
$22.28
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $84.2k 4,673 shares
Last Trade
Jan 31, 2024 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$24.2k 1,183 shares
$20.49
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $62.9k 3,490 shares
Last Trade
Jul 31, 2023 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$18.4k 862 shares
$21.32
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Chief Financial Officer
Holding Value $47.4k 2,628 shares
Last Trade
Jun 13, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$12.9k 577 shares
$22.31
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Holding Value $1.98M 110,000 shares
Last Trade
Feb 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.14M 110,000 shares
$28.55
$18.02
Syndax Pharmaceuticals
Syndax Pharmaceuticals SNDX
Director, Chief Financial Officer
Holding Value $4.14M 230,000 shares
Last Trade
Jun 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.59M 233,205 shares
$15.39
$18.02
OptiNose
OptiNose OPTN
Chief Financial Officer
Holding Value $1.36M 141,726 shares
Last Trade
Mar 16, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$145k 4,617 shares
$31.50
$9.60

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up